Combination of angiopoietin-2 antagonist and of vegf-a, kdr...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2633211

The invention relates to agents which possess anti-angiogenic activity and are accordingly useful in methods of treatment of disease states associated with angiogenesis in the animal or human body. More specifically the invention concerns a combination of an antagonist of the biological activity of Angiopoietin-2 and an antagonist of the biological activity of VEGF-A, and/or KDR, and/or Flt1, and uses of such antagonists.

L'invention porte sur des agents à activité antiangiogène et donc utiles dans des méthodes de traitement d'états morbides associés à l'angiogenèse, chez l'animal ou l'homme. L'invention porte sur plus spécifiquement, sur la combinaison d'un antagoniste de l'activité biologique de l'angiopoïétine 2 et d'un antagoniste de l'activité biologique du VEGF-A et/ou du KDR et/ou du Fltl, et sur les utilisations de tels antagonistes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of angiopoietin-2 antagonist and of vegf-a, kdr... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of angiopoietin-2 antagonist and of vegf-a, kdr..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of angiopoietin-2 antagonist and of vegf-a, kdr... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1418731

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.